跳至主要内容
临床试验/NCT00817245
NCT00817245已完成1 期

Effect of Helicobacter Pylori Treatment on Remission of Idiopathic Central Serous Chorioretinopathy (ICSCR)

Tabriz University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Subretinal fluid level

研究概览

简要总结

Etiology of ICSCR is not known however recent studies regard the role of immunologic and infectious processes in the pathogenesis of ICSCR.one of these hypothesis is the role of helicobacter pylori in the pathogenesis of ICSCR so perhaps treatment of h pylori have positive effect on the remission of ICSCR.

详细描述

we will choose 50 cases of patients with ICSCR who are infected with h.pylori.25 cases will receive anti h.pylori regiment and 25 cases as controls will receive no medication.then we will compare the time of submacular fluid resorption and macular thickness and visual acuity among these two groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
28 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • the persons who are infected with helicobacter pylori and have ICSCR

排除标准

  • history of previous eye surgery ,to have indication of laser therapy,corticosteroid therapy,pregnancy,

研究组 & 干预措施

1

Active Comparator

Oral Amoxicillin Capsule Metronidazole Tablet Omeprazole Capsule

干预措施: omeprazole, Amoxicillin, metronidazole (Drug)

结局指标

主要结局

Subretinal fluid level

次要结局

  • time of sub macular fluid absorption

研究者

发起方
Tabriz University
申办方类型
Other

研究点 (1)

Loading locations...

相似试验